A precise understanding of how the enzyme topoisomerase II cuts DNA could lead to better anti-cancer therapies.
New comprehensive functional MRI measurements point to the need to update models for assessing brain white matter activity and physiology.
Using gene transfer technologies to reprogram adult human kidney cells could lead to novel therapies for chronic kidney disease.
A nanobeacon imaging agent that binds specifically to colorectal cancer cells may aid the early detection of cancer during colonoscopy.
The discovery that kidney cells with mutations in a certain gene are sensitive to therapies called PI3K inhibitors opens new opportunities for applying precision medicine to cancer treatment.
Understanding how natural brain chemicals with pain-relieving properties interact with administered opioids may guide personalized approaches for pain management.